N. Ivgy-may

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype

J. Ramaekers, E. Theunissen, S. Conen, 2011, Psychopharmacology.

Critical and optimal Ig domains for promotion of neurite outgrowth by L1/Ng-CAM.

M. Schachner, D. Friedlander, J. Haspel, 2000, Journal of neurobiology.

Esmirtazapine for the Treatment of Chronic Primary Insomnia: A Randomized Long-Term Safety Study in Elderly Outpatients

A. Pong, N. Ivgy-may, A. Winokur, 2020 .

Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study, and open-label extension.

G. Hajak, T. Roth, S. Braat, 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Synaptic properties of serotonergic growth cones in developing rat brain

H. Tamir, M. Gershon, N. Ivgy-may, 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.

A. Krystal, T. Roth, N. Ivgy-may, 2015, Sleep medicine.

Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.

T. Roth, N. Ivgy-may, J. Walsh, 2015, Sleep medicine.

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

C. Lines, A. Krystal, K. Connor, 2016, Biological Psychiatry.

A Phase 2 Randomized Dose-Finding Study With Esmirtazapine in Patients With Primary Insomnia

T. Roth, G. Zammit, N. Ivgy-may, 2016, Journal of clinical psychopharmacology.

Comparison of eeg power spectra between patients with primary insomnia and good sleeper controls, accounting for the effects of age, gender, and sleep period, using a large compilation of PSG recordings from three clinical trials

V. Svetnik, Junshui Ma, E. Snyder, 2013 .